EVUSHELD

I've been following the progress of Evusheld since late last summer when it first appeared on my horizon. While it may not be useful for everyone, I'm excited about it's potential for those who have zero antibody response to Sars-CoV-2 vaccination. It's early days and I would certainly look to my medical team for guidance on whether or not it's appropriate for my particular circumstance.

AZ did make a statement to the effect that the formulation retains activity against the Omicron variant in lab studies. Have not seen anything yet with Omicron patient data though.